Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
382.25
-5.39 (-1.39%)
Jul 30, 2026, 12:12 PM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Prolia Revenue
4.04B4.41B4.37B
ENBREL Revenue
2.04B2.23B3.32B
XGEVA Revenue
1.93B2.08B2.23B
Repatha Revenue
3.24B3.02B2.22B
Otezla Revenue
2.26B2.27B2.13B
TEPEZZA Revenue
2.01B1.90B1.85B
EVENITY Revenue
2.22B2.10B1.56B
KYPROLIS Revenue
1.42B1.41B1.50B
Nplate Revenue
1.62B1.52B1.46B
Aranesp Revenue
1.36B1.39B1.34B
BLINCYTO Revenue
1.60B1.56B1.22B
KRYSTEXXA Revenue
1.36B1.34B1.19B
Vectibix Revenue
1.20B1.18B1.05B
TEZSPIRE Revenue
1.54B1.48B972.00M
Other Products Revenue
7.66B7.26B5.63B
Product Revenue
35.49B35.15B32.03B
Other Revenue
1.73B1.60B1.40B
Revenue (Total)
37.22B36.75B33.42B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
U.S. Revenue
-26.42B23.86B
Rest of World (ROW) Revenue
-10.33B9.56B
Revenue (Total)
37.22B36.75B33.42B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
McKesson Corporation Revenue
26.25B22.17B
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue
20.99B18.39B
Cardinal Health, Inc. Revenue
12.56B11.28B